29.92
0.09 (0.30%)
Previous Close | 29.83 |
Open | 30.06 |
Volume | 180,810 |
Avg. Volume (3M) | 280,214 |
Market Cap | 1,027,704,128 |
Price / Earnings (TTM) | 44.00 |
Price / Earnings (Forward) | 25.25 |
Price / Sales | 1.33 |
Price / Book | 5.71 |
52 Weeks Range | |
Earnings Date | 26 Feb 2025 - 3 Mar 2025 |
Profit Margin | 3.24% |
Operating Margin (TTM) | 5.98% |
Diluted EPS (TTM) | 0.680 |
Quarterly Revenue Growth (YOY) | 28.90% |
Quarterly Earnings Growth (YOY) | 41.60% |
Total Debt/Equity (MRQ) | 201.24% |
Current Ratio (MRQ) | 1.12 |
Operating Cash Flow (TTM) | 23.91 M |
Levered Free Cash Flow (TTM) | 2.17 M |
Return on Assets (TTM) | 3.83% |
Return on Equity (TTM) | 13.67% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Care Facilities (US) | Mixed | Mixed |
Medical Care Facilities (Global) | Mixed | Mixed | |
Stock | The Pennant Group, Inc. | Bullish | Bullish |
AIStockmoo Score
Analyst Consensus | 3.0 |
Insider Activity | NA |
Price Volatility | -1.0 |
Technical Moving Averages | -2.5 |
Technical Oscillators | -0.5 |
Average | -0.25 |
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses. |
|
Sector | Healthcare |
Industry | Medical Care Facilities |
Investment Style | Small Growth |
% Held by Insiders | 3.95% |
% Held by Institutions | 78.73% |
Ownership
Name | Date | Shares Held |
---|---|---|
Crewe Advisors Llc | 30 Sep 2024 | 742,958 |
Boone Capital Management Llc | 30 Sep 2024 | 641,255 |
52 Weeks Range | ||
Price Target Range | ||
High | 40.00 (Stephens & Co., 33.69%) | Buy |
Median | 38.00 (27.01%) | |
Low | 33.00 (Wells Fargo, 10.29%) | Hold |
Average | 37.20 (24.33%) | |
Total | 3 Buy, 2 Hold | |
Avg. Price @ Call | 32.44 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Wells Fargo | 19 Dec 2024 | 33.00 (10.29%) | Hold | 28.15 |
Oppenheimer | 08 Nov 2024 | 37.00 (23.66%) | Buy | 33.42 |
RBC Capital | 23 Oct 2024 | 38.00 (27.01%) | Buy | 34.15 |
Stephens & Co. | 09 Oct 2024 | 40.00 (33.69%) | Buy | 33.92 |
Truist Securities | 07 Oct 2024 | 38.00 (27.01%) | Hold | 32.57 |
No data within this time range.
Date | Type | Details |
---|---|---|
17 Dec 2024 | Announcement | Kno2 and Pennant Announce Strategic Partnership to Revolutionize Patient Care through QHIN services |
11 Nov 2024 | Announcement | Pennant Group to Participate in the 2024 Stephens Annual Investment Conference |
06 Nov 2024 | Announcement | Pennant Reports Third Quarter 2024 Results |
01 Nov 2024 | Announcement | Pennant Acquires Senior Living Communities in Wisconsin |
21 Oct 2024 | Announcement | Pennant Announces Third Quarter 2024 Earnings Release and Call |
02 Oct 2024 | Announcement | The Pennant Group Announces Pricing of Public Offering of Common Stock |
30 Sep 2024 | Announcement | The Pennant Group Announces Public Offering of Common Stock |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2024 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |